 |
Business Insights have teamed up with global drug discovery experts to bring you a unique series of reports providing in-depth analysis into the future of the drug discovery sector.
The Drug Discovery series is a new set of reports that tackle the issues impeding innovation for R&D executives and assess the cutting edge approaches and technologies companies can use to overcome the productivity gap. Click here to find out more. |
 |
| |
|
 |
 |
Each Business Insights Drug Discovery publication is independently authored by a leading expert in their field.
Our Drug Discovery Series includes publications on: Immunomodulators, RNAi, translational medicines, stem cell research, ADME & toxicology, biomarkers, array technologies, metabolomics, strategic product strategies, emerging pharma markets and much more...
Browse our Drug Discovery titles
|
|
| |
|
|
 |
New Report-Innovations in Protein Kinase Therapies
Aberrant kinase activity has been directly implicated in the etiology of a wide spectrum of human pathologies. As a result of their importance, approximately 30% of current discovery and development spending focuses on kinases, especially in the fields of oncology, inflammation and metabolic diseases.
Table of contents | More information
|
|
| |
|
 |
Use the quick jump menu below to go straight to the resources you are interested in.
The Drug Discovery series of reports are published by Business Insights Ltd.
|
|
|
 |
All our Drug Discovery titles are available through our report library. For instant access purchase by credit card, or download our order form. If you have any questions regarding any of the publications in this series please contact info@globalbusinessinsights.com |
|
|
 |
Click here for further information on our drug discovery affiliate partners.
|
|
|
